Braune, S., Lang, M., & Bergmann, A. (2013). Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort. Springer Berlin Heidelberg.
Citação norma ChicagoBraune, Stefan, M. Lang, and A. Bergmann. Second Line Use of Fingolimod Is As Effective As Natalizumab in a German Out-patient RRMS-cohort. Springer Berlin Heidelberg, 2013.
Citação norma MLABraune, Stefan, M. Lang, and A. Bergmann. Second Line Use of Fingolimod Is As Effective As Natalizumab in a German Out-patient RRMS-cohort. Springer Berlin Heidelberg, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.